Post-placental Intrauterine Device Insertion During Cesarean Section

Intrauterine Device Migration Clinical Trial

Official title: Hang-up Versus Non-fixation Technique for Immediate Post-placental Intrauterine Device Insertion During Cesarean Section

Status Completed

Clinical Trial Summary

Effective, reversible postpartum contraception decreases the chance of rapid repeat pregnancy and poor perinatal outcome in a subsequent pregnancy especially in women delivered by cesarean section.The traditional 6-week postpartum visits not evidenced based and may not meet patient needs, particularly with respect to provision of contraception.Intrauterine device placement after delivery of the placenta is an appealing strategy for increasing access to postpartum Intrauterine device because it does not require a separate postpartum visit.

Advantage of post-placental Intrauterine device insertion, Intrauterine devices are recommended as first-line contraceptives by the American Academy of Pediatricians. The Centers for Disease Control and Prevention united state . Medical Eligibility Criteria for Contraceptive Use places no restrictions on use, and states advantages generally outweigh the risks for immediate postpartum use of Intrauterine devices.

Clinical Trial Description

n/a

Related Conditions & MeSH terms

• Intrauterine Device Migration

• NCT number: NCT03780985
• Study type: Interventional
• Source: Assiut University
• Status: Completed
• Phase: N/A
• Start date: January 1, 2019
• Completion date: April 1, 2020